The Impact of Reoperations Following Bariatric Surgery on Mid-term Outcomes.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
04 2023
Historique:
received: 31 08 2022
accepted: 15 02 2023
revised: 14 02 2023
medline: 10 4 2023
pubmed: 25 2 2023
entrez: 24 2 2023
Statut: ppublish

Résumé

With the obesity epidemic, the number of bariatric procedures is increasing, and although considered relatively safe, major postoperative complications still occur. In cancer surgery, major complications such as reoperations have been associated with deteriorated mid/long-term outcomes. In obesity surgery, the effects of reoperations on postoperative weight loss and associated comorbidities remain unclear. The aim of this study was to assess mid-term weight loss and comorbidities following early reoperations in obesity surgery. A population-based cohort study was performed within the Dutch Audit for Treatment of Obesity (DATO), including all patients that underwent a primary gastric bypass procedure or sleeve gastrectomy. Follow-up data was collected up until 5 years postoperatively on percentage total weight loss (%TWL) and comorbidities. A total of 40,640 patients underwent a gastric bypass procedure or sleeve gastrectomy between 2015 and 2018. Within this cohort, 709 patients (1.7%) suffered a major complication requiring reoperation within 30 days. %TWL at 24 months was 33.1 ± 9.2 in the overall population, versus 32.9 ± 8.7 in the patients who underwent a reoperation (p=0.813). Both analysis per year and Cox regression techniques revealed no differences in long-term follow-up regarding percentage TLW, and weight loss success rates (%TWL>20%) in patients who underwent a reoperation compared to patients without reoperation. At 5 years, the availability of follow-up data was low. No differences were observed in the remission of comorbidities. Major complications requiring reoperation within 30 days of gastric bypass surgery or sleeve gastrectomy did not affect long-term outcomes with regard to weight loss or remission of comorbidities.

Identifiants

pubmed: 36826677
doi: 10.1007/s11695-023-06519-0
pii: 10.1007/s11695-023-06519-0
pmc: PMC10079741
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1237-1244

Informations de copyright

© 2023. The Author(s).

Références

Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;2014 https://doi.org/10.1002/14651858.CD003641.pub4 .
Poelemeijer YQM, Liem RSL, Nienhuijs SW. A Dutch nationwide bariatric quality registry: DATO. Obes Surg. 2018;28:1602–10. https://doi.org/10.1007/s11695-017-3062-2 .
doi: 10.1007/s11695-017-3062-2 pubmed: 29273926
Abelson P, Kennedy D. The obesity epidemic. Science. 2004;304:1413. https://doi.org/10.1126/science.304.5676.1413 .
doi: 10.1126/science.304.5676.1413 pubmed: 15178768
Lee W-J, Almalki O. Recent advancements in bariatric/metabolic surgery. Ann Gastroenterol Surg. 2017;1:171–9. https://doi.org/10.1002/ags3.12030 .
doi: 10.1002/ags3.12030 pubmed: 29863165 pmcid: 5881368
Chen J-Y, Lin G-T, Chen Q-Y, et al. Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: a large sample analysis. Eur J Surg Oncol. 2022;S0748-7983(22):00475–9. https://doi.org/10.1016/j.ejso.2022.05.025 .
doi: 10.1016/j.ejso.2022.05.025
Dolin TG, Christensen IJ, Lund CM, et al. Preoperative plasma vitamin D in patients with localized colorectal cancer: age-dependent association with inflammation, postoperative complications, and survival. Eur J Surg Oncol. 2022;S0748-7983(22):00651–5. https://doi.org/10.1016/j.ejso.2022.08.040 .
doi: 10.1016/j.ejso.2022.08.040
Hjorth S, Näslund I, Andersson-Assarsson JC, et al. Reoperations After bariatric surgery in 26 years of follow-up of the Swedish Obese Subjects Study. JAMA Surg. 2019;154:319–26. https://doi.org/10.1001/jamasurg.2018.5084 .
doi: 10.1001/jamasurg.2018.5084 pubmed: 30601881 pmcid: 6484798
Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA Surg. 2018;153:427–34. https://doi.org/10.1001/jamasurg.2017.5025 .
doi: 10.1001/jamasurg.2017.5025 pubmed: 29214306
Kowalewski PK, Olszewski R, Walędziak MS, et al. Long-term outcomes of laparoscopic sleeve gastrectomy—a single-center, retrospective study. Obes Surg. 2018;28:130–4. https://doi.org/10.1007/s11695-017-2795-2 .
doi: 10.1007/s11695-017-2795-2 pubmed: 28707172
Bartosiak K, Janik MR, Walędziak M, et al. Effect of significant postoperative complications on decision regret after laparoscopic sleeve gastrectomy: a case-control study. Obes Surg. 2022;32(8):2591–7. https://doi.org/10.1007/s11695-022-06113-w .
doi: 10.1007/s11695-022-06113-w pubmed: 35619046 pmcid: 9273554
Mizera M, Wysocki M, Walędziak M, et al. The impact of severe postoperative complications on outcomes of bariatric surgery-multicenter case-matched study. Surg Obes Relat Dis. 2022;18:53–60. https://doi.org/10.1016/j.soard.2021.09.022 .
doi: 10.1016/j.soard.2021.09.022 pubmed: 34736868
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4. https://doi.org/10.1001/jama.2013.281053 .
doi: 10.1001/jama.2013.281053
Corcelles R, Boules M, Froylich D, et al. Total weight loss as the outcome measure of choice after Roux-en-Y gastric bypass. Obes Surg. 2016;26:1794–8. https://doi.org/10.1007/s11695-015-2022-y .
doi: 10.1007/s11695-015-2022-y pubmed: 26803753
DATO. DICA n.d. http://dica.nl/jaarrapportage-2019/dato (accessed July 6, 2022).
Verhoeff K, Mocanu V, Jogiat U, et al. Patient selection and 30-day outcomes of SADI-S compared to RYGB: a retrospective cohort study of 47,375 patients. Obes Surg. 2022;32(7):1–8. https://doi.org/10.1007/s11695-022-06068-y .
doi: 10.1007/s11695-022-06068-y pubmed: 35445967 pmcid: 9022408
Kamiya H, Komatsu S, Ohashi T, et al. Postoperative complications and open gastrectomy affect non-cancer-related death and shorten life expectancy in elderly patients with gastric cancer. Am J Cancer Res. 2021;11:5038–44.
pubmed: 34765310 pmcid: 8569366
Jiang N, Deng J-Y, Ding X-W, et al. Effect of complication grade on survival following curative gastrectomy for carcinoma. World J Gastroenterol. 2014;20:8244–52. https://doi.org/10.3748/wjg.v20.i25.8244 .
doi: 10.3748/wjg.v20.i25.8244 pubmed: 25009399 pmcid: 4081699
Sugawara K, Yagi K, Aikou S, et al. Impacts of complications after esophageal cancer surgery on health-related quality of life and nutritional status. Gen Thorac Cardiovasc Surg. 2022;70(12):1048–57. https://doi.org/10.1007/s11748-022-01846-y .
doi: 10.1007/s11748-022-01846-y pubmed: 35788889
Katsube T, Konnno S, Murayama M, et al. Changes of nutritional status after distal gastrectomy in patients with gastric cancer. Hepatogastroenterology. 2008;55:1864–7.
pubmed: 19102410
Mulita F, Lampropoulos C, Kehagias D, et al. Long-term nutritional deficiencies following sleeve gastrectomy: a 6-year single-centre retrospective study. Prz Menopauzalny. 2021;20:170–6. https://doi.org/10.5114/pm.2021.110954 .
doi: 10.5114/pm.2021.110954 pubmed: 35069068 pmcid: 8764960
Molero J, Olbeyra R, Flores L, et al. Prevalence of low skeletal muscle mass following bariatric surgery. Clin Nutr ESPEN. 2022;49:436–41. https://doi.org/10.1016/j.clnesp.2022.03.009 .
doi: 10.1016/j.clnesp.2022.03.009 pubmed: 35623849
Rea JD, Yarbrough DE, Leeth RR, et al. Influence of complications and extent of weight loss on quality of life after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2007;21:1095–100. https://doi.org/10.1007/s00464-007-9257-1 .
doi: 10.1007/s00464-007-9257-1 pubmed: 17353983

Auteurs

Jennifer Straatman (J)

Department of Gastrointestinal Surgery, Rode Kruis Ziekenhuis, Vondellaan 13, 1942 LE, Beverwijk, Netherlands. je.straatman@amsterdamumc.nl.

Ahmet Demirkiran (A)

Department of Gastrointestinal Surgery, Rode Kruis Ziekenhuis, Vondellaan 13, 1942 LE, Beverwijk, Netherlands.

Niels J Harlaar (NJ)

Department of Gastrointestinal Surgery, Rode Kruis Ziekenhuis, Vondellaan 13, 1942 LE, Beverwijk, Netherlands.

Huib A Cense (HA)

Department of Gastrointestinal Surgery, Rode Kruis Ziekenhuis, Vondellaan 13, 1942 LE, Beverwijk, Netherlands.

Frederik H W Jonker (FHW)

Department of Gastrointestinal Surgery, Rode Kruis Ziekenhuis, Vondellaan 13, 1942 LE, Beverwijk, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH